IntelGenx Technologies Corp. (IGX) Fundamentals

Intelgenx Technologies Corp is an oral drug delivery company. The company is focused on the development and manufacturing of pharmaceutical oral films based on its proprietary VersaFilmTM technology platform. Intelegenx focuses on the development of novel oral immediate-release and controlled-release products for the pharmaceutical market. It offers a comprehensive portfolio of pharmaceutical services, including pharmaceutical R&D, clinical monitoring, regulatory support, tech transfer and manufacturing scale-up, and commercial manufacturing. Its geographical segments are Europe, Canada, and United States.
SHARE INFORMATION
Market Cap$ 34,929,239
Shares Outstanding174,646,197
Float124,292,296
Percent Float71.17%
Short Interest2,191.00
Short Percent Float100.0%
Short Interest Ratio0.029464
Short Interest Date2022-11-15
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 1,940,109
Latest Fiscal EPS$ -0.09
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions1
Institutional Holdings Date2022-06-30
Institutional Bought Previous 3 Months-
Institutional Holdings Percent0.0%
Institutional Sold Previous 3 Months-
Insider Holdings Date2018-11-30
Insider Bought Previous 3 Months-
Insider Holdings Percent1.2
Insider Sold Previous 3 Months-
Insider Shares Owned28,062,132
TRADING INFO
52 Week High$ 0.62
52 Week Low$ 0.15
52 Week High Change$ -66.67
21 Day Moving Average$ 0.213333
21 Day Extended Moving Average$ 0.212872
50 Day Moving Average$ 0.1983
50 Day Extended Moving Average$ 0.21048
200 Day Moving Average$ 0.27515
200 Day Extended Moving Average$ 0.279815
10 Day Average Volume17,089
20 Day Average Volume11,260
30 Day Average Volume22,470
50 Day Average Volume38,490
Alpha-0.005239
Beta3.344695
Standard Deviation0.269909
R20.299253
7 Day Price Change$ -0.005
7 Day Percent Change-2.44%
21 Day Price Change$ -0.015
21 Day Percent Change-6.98%
30 Day Price Change$ -0.045
30 Day Percent Change-18.37%
Month to Date Price Change$ -0.035
Month to Date Percent Change-14.89%
Quarter to Date Price Change$ 0.03
Quarter to Date Percent Change17.65%
180 Day Price Change$ -0.115
180 Day Percent Change-36.51%
200 Day Price Change$ -0.12
200 Day Percent Change-37.5%
Year to Date Price Change$ -0.26
Year to Date Percent Change-56.52%

IntelGenx Technologies Corp. (IGX) Key Ratios

PROFITABILITY
EBIT Margin-738.8%
EBITDA Margin-676.7%
Pre-Tax Profit Margin-617.0%
Profit Margin Count0.0%
Gross Margin-60.4%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 1,624,786
Revenue Per Share$ 0.009303
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book-24.15
Total Debt To Equity6.42
Int Coverage-6.60
Current Ratio2.60
Leverage Ratio12.70
Quick Ratio2.40
Long Term Debt To Capital0.86
VALUATION MEASURES
PE Ratio-2.00
Enterprise Value$ 44,347,599
Price to Sales21.4977
Price to Free Cash-2.90
PE High Last 5 Years-5.00
Price To Book16.99
Price To Cash Flow34.20
PE Low Last 5 Years-30.70
Price to Tangible Book-24.15
MANAGEMENT EFFECTIVENESS
Receivables Turnover1.30
Invoice Turnover28.60
Assets Turnover0.10
Return Assets-71.36
Return on Equity-591.63
Return on Capital-68.43

IntelGenx Technologies Corp. (IGX) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorRichter S.E.N.C.R.L./LLP
CEOHorst G. Zerbe
Emplyoees51
Last AuditUQ
CIK0001098880
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address6420 Abrams
Ville Saint Laurent, QC H4S 1Y2
Websitehttps://www.intelgenx.com
Facsimile+1 514 331-0436
Telephone+1 514 331-7440
Emailstephen@intelgenx.com
Your Recent History
TSXV
IGX
Intelgenx ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:ca D:20221205 04:07:24